Main > NEUROLOGY. > CH. R. NMOSD>Treat.>IL-6 Receptor>

---

CH. R. NMOSD>Treat.>IL-6 Receptor>'s subsections
(*) CA Approval Date: 2020. 08.31
(*) CH Approval Date: ?
(*) JP Approval Date: ?
(*) USA Approval Date: 2020. 08.17
>MAb SC Injection
Company
Company Licensee CA
Company Licensee JP
Company Licensee USA
Generic Name: SatralizuMAb
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: >2
Patent>UpDate: 2021. 12.21
Product Web-Site (USA)

CH. R. NMOSD>Treat.>IL-6 Receptor>'s products
This section has no products